Matching-adjusted indirect comparison of cabozantinib (C) versus regorafenib (R) in advanced hepatocellular carcinoma (HCC) Meeting Abstract


Authors: Venerito, M.; Kelley, R. K.; Mollon, P.; Blanc, J. F.; Daniele, B.; Yau, T.; Cheng, A. L.; Valcheva, V.; Remiro Azocar, A.; Baio, G.; Li, Y.; Abou-Alfa, G. K.
Abstract Title: Matching-adjusted indirect comparison of cabozantinib (C) versus regorafenib (R) in advanced hepatocellular carcinoma (HCC)
Meeting Title: 34. Deutscher Krebskongress (DKK)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 1
Meeting Dates: 2020 Feb 19-22
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-02-01
Start Page: 60
Language: English
ACCESSION: WOS:000517158700150
PROVIDER: wos
DOI: 10.1159/000506491
Notes: "34th German Cancer Congress" -- Meeting Abstract: 172 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa